Advertisement

  • BRCA: Who Should Be Tested?

    Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

    by Sue Rochman

  • FORWARD LOOK

    Screening for Lung Cancer in Rural Areas

    Programs aim to increase awareness of benefits.

    by Sue Rochman

  • Cancer Takes an Unequal Toll on Employment

    In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

    by Pamela Rafalow Grossman

  • First Ladies of Africa Issue Call to Address Cancer Crisis

    A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.

    by Bradley D. Miller, PhD

  • HIV Can Worsen Cancer Treatment Outcomes

    People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

    by Jon Kelvey

  • Why Is the Rate of Uterine Cancer Rising?

    Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

    by Ashley P. Taylor

  • Cancer Care on a Native American Reservation

    For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.

    by Kate Yandell

  • Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event

    Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.

    by Kevin McLaughlin

  • Getting a Read on Cancer

    Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.

    by Kate Yandell

  • Reinforcements for Cancer Research

    Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.

    by Marci A. Landsmann

Advertisement
Advertisement

From the AACR

  • Cervical Cancer Awareness Month

    Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.

  • New FDA Approvals

    The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.

  • Imaging and Immunotherapy

    Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR